Current Environment:

Sharon Levy | Medical Services

Languages

  • English

Sharon Levy | Education

Medical School

New York University School of Medicine

1992, New York, NY

Internship

New York University School of Medicine/Bellvue Hospital

1993, New York, NY

Residency

New York University School of Medicine

1996, New York, NY

Fellowship

Boston Children's Hospital

1999, Boston, MA

Sharon Levy | Professional History

Sharon Levy, MD, MPH is a board certified Developmental-Behavioral Pediatrician and an Assistant Professor of Pediatrics at Harvard Medical School. She is the Director of the Adolescent Substance Abuse Program (ASAP) in the Division of Developmental Medicine at Boston Children's Hospital, which is comprised of clinical, research, training and policy arms. She has evaluated and treated thousands of adolescents with substance use disorders, and has taught national curricula and published extensively on the outpatient management of substance use disorders in adolescents, including screening and brief advice in primary care, the use of drug testing and the outpatient management of opioid dependent adolescents. She is currently the co-PI of a SAMHSA-funded adolescent SBIRT project, an NIAAA-funded study validating the youth alcohol screening tool in a population of youth with chronic medial illness, and a Conrad N. Hilton funded study that aims to validate adolescent SBIRT measures and test a brief intervention for medically vulnerable youth.

Sharon Levy | Publications

I completed my Pediatric internship, residency training and a Chief Residency at New York University Medical Center/Bellevue Hospital in New York City’s lower east side. At the time, in the early to middle 1990’s Bellevue Hospital cared for most of the homeless and indigent patients in New York City. As a trainee, I saw children and families plagued by poverty and all of its associated medical problems, including substance abuse. Medical staff members at Bellevue were trained to care for the conditions that resulted from substance use, but little training was devoted specifically to the treatment of substance-related disorders.

During this time period, I became interested in child and family advocacy, and after completing a year as a Chief Resident in Pediatrics, I accepted a Dyson Advocacy Training Fellowship in the Division of General Pediatrics at Children's Hospital Boston. After completing my training in 2000 I became the Director of Pediatrics for a new Adolescent Substance Abuse Program (ASAP). Shortly thereafter I received a career award from NIH to develop scientific skills in adolescent substance use disorders. In the ensuing years both clinical and research arms of ASAP have continued to grow and flourish.

ASAP is committed to delivering science based, family oriented, developmentally appropriate care for adolescents and young adults with substance use disorders. We are a "full spectrum" program, offering evaluation and treatment services for adolescents with a range of substance use experience, from new onset problems to addiction.